Document Type : Original Article (s)
Authors
1
Assistant Professor, Department of Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2
Associate Professor, Department of Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3
Epidemiologist, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4
Student of Medicine, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: One of the most prevalent intestinal cancers is rectum cancer causing 10% of mortality rate due to cancer. According to relative high prevalence of rectum cancer in Isfahan, Iran, the aim of this study was determining survival time and recurrent rate of this cancer in this region.Methods: This cross-sectional study for survival analysis was done in Alzahra hospital (Isfahan, Iran) during 2012-2013. 101 hospitalized consecutive patients with rectum cancer were selected. The necessary data such as demographic information, pathologic results and etc. were achieved from patients' records. We contacted patients' families for achieving completing data. All patients were followed for prognosis, death and recurrent after the surgery.Findings: The mean of survival time in all patients was 5.45 ± 0.45 years. According to Kaplan-Meier analysis, the median survival was 6.0 ± 0.9 years. Mean and median survival was statistically different based on the disease stage (P < 0.001); but other factors had not positive effect on patients' survival. The mean and median of relapse were 14.05 ± 2.30 and 12.00 ± 0.83 months, respectively. Chem-radiotherapy before the surgery statistically affected relapse time but other factors were not effective.Conclusion: Because of the high relapse and low survival rate in our patients in comparison with world statistics, protocols of treatment for rectum cancer must be revised.
Keywords